An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
Clinical trial NCT07344818 · RECRUITING
Trial details
- NCT number
- NCT07344818
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-07
- Primary completion
- 2027-03-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.